Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV AMD3100 for Stem Cell Mobilization in HLA-Matched Sibling Donors
NCT00914849Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), non-Hodgkin lymphoma (NHL), sponsored by Washington University School of Medicine. Started Aug 2009; status: completed.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00914849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914849.